Annals of Oncology

News:

Do you Euro?
Ann Oncol 13: 337-341; doi:10.1093/annonc/mdf161
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Editorials:

J. Bergh

Is pharmacokinetically guided chemotherapy dosage a better way forward?
Ann Oncol 13: 343-344; doi:10.1093/annonc/mdf145
[Extract] [FREE Full Text] [PDF] [Request Permissions]

G. R. Laking and P. M. Price

FDG-PET for response assessment: answers in search of questions
Ann Oncol 13: 345-347; doi:10.1093/annonc/mdf144
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

A. B. Hassan and V. M. Macaulay

The insulin-like growth factor system as a therapeutic target in colorectal cancer
Ann Oncol 13: 349-356; doi:10.1093/annonc/mdf096
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. Salminen and M. Mac Manus

FDG-PET imaging in the management of non-small-cell lung cancer
Ann Oncol 13: 357-360; doi:10.1093/annonc/mdf106
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Gastrointestinal tumors:

P. Flamen, E. Van Cutsem, A. Lerut, J.-P. Cambier, K. Haustermans, G. Bormans, P. De Leyn, D. Van Raemdonck, W. De Wever, N. Ectors, A. Maes, and L. Mortelmans

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
Ann Oncol 13: 361-368; doi:10.1093/annonc/mdf081
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Levi, C. Pasche, F. Lucchini, and C. La Vecchia

Macronutrients and colorectal cancer: a Swiss case-control study
Ann Oncol 13: 369-373; doi:10.1093/annonc/mdf110
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

A. D. R. Huitema, M. Spaander, R. A. A. Mathôt, M. M. Tibben, M. J. Holtkamp, J. H. Beijnen, and S. Rodenhuis

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin
Ann Oncol 13: 374-384; doi:10.1093/annonc/mdf052
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

D. Schrijvers, A. M. E. Bos, J. Dyck, E. G. E. de Vries, J. Wanders, M. Roelvink, P. Fumoleau, S. Bortini, and J. B. Vermorken

Phase I study of MEN-10755, a new anthracycline in patients with solid tumours: a report from the European Organization for Research and Treatment of Cancer, Early Clinical Studies Group
Ann Oncol 13: 385-391; doi:10.1093/annonc/mdf061
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Tortora, F. Ciardiello, V. Damiano, M. De Laurentiis, E. Matano, S. Pepe, M. Pensabene, G. Catalano, S. De Placido, and A. R. Bianco

Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer
Ann Oncol 13: 392-398; doi:10.1093/annonc/mdf030
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. B. Simpson, P. M. Calvert, J. A. Sludden, A. V. Boddy, M. J. Griffin, A. Schätzlein, P. Wilson, K. Fishwick, A. Wheatley, G. A. Ross, A. H. Calvert, and C. J. Twelves

Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules
Ann Oncol 13: 399-402; doi:10.1093/annonc/mdf041
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

C. Pöttgen, W. Eberhardt, S. Bildat, G. Stüben, G. Stamatis, L. Hillejan, S. Sohrab, H. Teschler, S. Seeber, H. Sack, and M. Stuschke

Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial
Ann Oncol 13: 403-411; doi:10.1093/annonc/mdf050
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

D. A. Vorobiof, B. L. Rapoport, M. R. Chasen, R. P. Abratt, N. Cronje, L. Fourie, G. McMichael, and D. Hacking

Malignant pleural mesothelioma: a phase II trial with docetaxel
Ann Oncol 13: 412-415; doi:10.1093/annonc/mdf046
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

A. F. Ferreira Filho, A. Di Leo, M. Paesmans, M. Beauduin, A. Vindevoghel, J. Michel, C. Focan, A. Awada, F. Cardoso, S. Dolci, S. Bartholomeus, and M. J. Piccart

The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
Ann Oncol 13: 416-421; doi:10.1093/annonc/mdf051
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. L. Silva, M. J. Tomé, A. E. Correia, and J. L. Passos-Coelho

Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products
Ann Oncol 13: 422-429; doi:10.1093/annonc/mdf107
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gynecologic tumors:

J. Fujimoto, I. Aoki, S. Khatun, H. Toyoki, and T. Tamaya

Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers
Ann Oncol 13: 430-434; doi:10.1093/annonc/mdf078
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Urogenital tumors:

C. J. Sweeney, F. J. Monaco, S.-H. Jung, M. J. Wasielewski, J. Picus, R. H. Ansari, W. M. Dugan, and L. H. Einhorn

A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer
Ann Oncol 13: 435-440; doi:10.1093/annonc/mdf029
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Donskov, H. von der Maase, R. Henriksson, U. Stierner, P. Wersäll, H. Nellemann, K. Hellstrand, K. Engman, and P. Naredi

Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon- in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study
Ann Oncol 13: 441-449; doi:10.1093/annonc/mdf049
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

C. Hosing, M. Munsell, S. Yazji, B. Andersson, D. Couriel, M. de Lima, M. Donato, J. Gajewski, S. Giralt, M. Körbling, T. Martin, N. T. Ueno, R.E. Champlin, and I.F. Khouri

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin’s lymphoma
Ann Oncol 13: 450-459; doi:10.1093/annonc/mdf109
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Pediatric malignancies:

A. M. Abu-Ghosh, M. D. Krailo, S. C. Goldman, R. S. Slack, V. Davenport, E. Morris, J. H. Laver, G. H. Reaman, and M. S. Cairo

Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report
Ann Oncol 13: 460-469; doi:10.1093/annonc/mdf028
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Clinical trials:

R. Fossati, C. Confalonieri, G. Apolone, S. Cavuto, and S. Garattini

Does a drug do better when it is new?
Ann Oncol 13: 470-473; doi:10.1093/annonc/mdf053
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Clinical cases:

C. Théodore, N. Androulakis, A. Spatz, C. Goujard, P. Blanchet, and P. Wibault

An explosive course of squamous cell penile cancer in an AIDS patient
Ann Oncol 13: 475-479; doi:10.1093/annonc/mdf024
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Benchalal, E. Yahchouchy-Chouillard, S. Fouere, and A. Fingerhut

Anaphylactic shock secondary to intravenous administration of folinic acid: a first report
Ann Oncol 13: 480-481; doi:10.1093/annonc/mdf023
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

S. M. Pupa, S. Forti, A. Balsari, and S. Ménard

Humoral immune response for early diagnosis of breast carcinoma
Ann Oncol 13: 483; doi:10.1093/annonc/mdf111
[Extract] [FREE Full Text] [PDF] [Request Permissions]

E. Van Cutsem, P. M. Hoff, J. L. Blum, M. Abt, and B. Osterwalder

Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil
Ann Oncol 13: 484-485; doi:10.1093/annonc/mdf108
[Extract] [FREE Full Text] [PDF] [Request Permissions]

V. C. G. Tjan-Heijnen, P. E. Postmus, and A. Ardizzoni

Reply to the article "Editorial comment on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study’", by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339–1340)
Ann Oncol 13: 485-486; doi:10.1093/annonc/mdf138
[Extract] [FREE Full Text] [PDF] [Request Permissions]

P. Bunn

Reply to "Letter to the Editor on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study’", by V. C. G. Tjan-Heijnen, P. E. Postmus & A. Ardizzoni (Ann Oncol 2002; 13: 485–486)
Ann Oncol 13: 486-487; doi:10.1093/annonc/mdf139
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

D. Amadori

K.K. Hunt, G.L. Robb, E.A. Strom, N.T. Ueno (eds). Breast Cancer
Ann Oncol 13: 489; doi:10.1093/annonc/mdf095
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. Esteller

K. Steinberg (ed). The Genetic Basis of Cancer
Ann Oncol 13: 490; doi:10.1093/annonc/mdf114
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. K. Hossfeld

E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
Ann Oncol 13: 490-491; doi:10.1093/annonc/mdf146
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Corrigenda:

Corrigendum
Ann Oncol 13: 493; doi:10.1093/annonc/mdf169
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.